4//SEC Filing
McGrath Lynne Fahey 4
Accession 0001214659-21-010561
CIK 0001677077other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 5:00 PM ET
Size
7.2 KB
Accession
0001214659-21-010561
Insider Transaction Report
Form 4
McGrath Lynne Fahey
Director
Transactions
- Exercise/Conversion
Common Stock
2021-10-15+47,222→ 50,000 total - Exercise/Conversion
Restricted Stock Grant
2021-10-15−47,222→ 50,000 totalExp: 2022-03-15→ Common Stock (47,222 underlying)
Footnotes (3)
- [F1]Represents the vesting of restricted stock.
- [F2]Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.
- [F3]The restricted stock grant was amended on October 13, 2021, such that 47,222 shares of restricted stock vested on October 15, 2021, and the remaining 50,000 shares of restricted stock shall vest on March 15, 2022. 2,778 shares previously vested on September 13, 2021.
Documents
Issuer
Alzamend Neuro, Inc.
CIK 0001677077
Entity typeother
Related Parties
1- filerCIK 0001866270
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 5:00 PM ET
- Size
- 7.2 KB